Anticancer drug targets: approaching angiogenesis

J Clin Invest. 1999 Dec;104(11):1497-501. doi: 10.1172/JCI8849.
No abstract available

Publication types

  • Review

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Angiostatins
  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Collagen / pharmacology
  • Endostatins
  • Endothelial Growth Factors / pharmacology
  • Endothelium, Vascular / drug effects
  • Extracellular Matrix / drug effects
  • Humans
  • Lymphokines / pharmacology
  • Neoplasms / blood supply
  • Neoplasms / drug therapy*
  • Neovascularization, Pathologic / prevention & control*
  • Peptide Fragments / pharmacology
  • Plasminogen / pharmacology
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Angiogenesis Inhibitors
  • Antineoplastic Agents
  • Endostatins
  • Endothelial Growth Factors
  • Lymphokines
  • Peptide Fragments
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Angiostatins
  • Plasminogen
  • Collagen